alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          NOV-30-1998
<PERIOD-START>                             DEC-01-1997
<PERIOD-END>                               NOV-30-1998
<CASH>                                           5,204
<SECURITIES>                                         0
<RECEIVABLES>                                   44,795
<ALLOWANCES>                                         0
<INVENTORY>                                     16,465
<CURRENT-ASSETS>                                73,260
<PP&E>                                          12,697
<DEPRECIATION>                                   7,971
<TOTAL-ASSETS>                                  82,533
<CURRENT-LIABILITIES>                           52,611
<BONDS>                                          1,238
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         2,965
<OTHER-SE>                                      18,268
<TOTAL-LIABILITY-AND-EQUITY>                    82,533
<SALES>                                        122,370
<TOTAL-REVENUES>                               122,370
<CGS>                                           83,719
<TOTAL-COSTS>                                   83,719
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 759
<INCOME-PRETAX>                                (5,822)
<INCOME-TAX>                                   (2,564)
<INCOME-CONTINUING>                            (3,258)
<DISCONTINUED>                                (10,375)
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (13,633)
<EPS-PRIMARY>                                   (4.60)
<EPS-DILUTED>                                   (4.60)
        

</TABLE>
III 

115TH CONGRESS 

2D SESSION S. RES. 703 

Expressing support for the goals of Stomach Cancer Awareness Month. 

IN THE SENATE OF THE UNITED STATES 

NOVEMBER 15, 2018 

Mr. YOUNG (for himself and Mr. DONNELLY) submitted the following resolution; which was referred to the Committee on Health, Education, Labor, 

and Pensions 

RESOLUTION 

Expressing support for the goals of Stomach Cancer 

Awareness Month. 

Whereas stomach cancer, also known as gastric cancer, is one 

of the most difficult cancers to detect in the early stages 

of the disease, which contributes to high mortality rates; 

Whereas stomach cancer occurs when cancer cells develop in 

the lining of the stomach; 

Whereas stomach cancer is the fifth most common type of 

cancer worldwide; 

Whereas, in 2018— 

(1) an estimated 26,240 cases of stomach cancer 

were diagnosed in the United States; and 

(2) it was estimated that 10,800 people in the 

United States would die from stomach cancer; 


pamtmann on DSKBFK8HB2PROD with BILLS
2 

•SRES 703 IS 

Whereas the estimated 5-year survival rate for stomach cancer is only 31 percent; 

Whereas approximately 1 in 111 individuals will be diagnosed 

with stomach cancer during his or her lifetime; 

Whereas, in the United States, stomach cancer is more prevalent among racial and ethnic minorities; 

Whereas increased awareness of, and education about, stomach cancer among patients and health care providers 

could improve timely recognition of stomach cancer symptoms; 

Whereas more research into early diagnosis, screening, and 

treatment for stomach cancer is needed; and 

Whereas November 2018 is an appropriate month to observe 

Stomach Cancer Awareness Month: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) supports the goals of Stomach Cancer 

3 Awareness Month; 

4 (2) supports efforts to increase awareness of, 

5 and education about, stomach cancer among the 

6 general public of the United States; 

7 (3) recognizes the need for additional research 

8 into early diagnosis, screening, and treatment for 

9 stomach cancer; and 

10 (4) encourages States and territories and local11 ities of the United States to support the goals of 

12 Stomach Cancer Awareness Month. 

Æ 


pamtmann on DSKBFK8HB2PROD with BILLS
Charles W. Schroeder, Elsie 

A. Schroeder Schneider, 

Hollis London, /s

Fourth Court of Appeals

San Antonio, Texas

April 6, 2015

No. 04-14-00167-CV

STEPHENS & JOHNSON OPERATING CO.; Henry W. Breyer, III, Trust; CAH, Ltd.-MOPI 

for Capital Account; CAH, Ltd.-Stivers Capital Account; CAH, Ltd.-Wiegand Resources Capital 

Account Wiegand Resources; C.T. Carden; Myrl W. Deitch Trust; E.R. Godbout Family Trust; 

Margaret J. Godbout; F.R. Keydel; R.L. Keydel; Pennye K. Maloney; David R. McNitt; RCA 

Trust One; Donald B. Scott; Sunset Production Corporation; Genessee Country Museum,

Appellants

v.

Charles W. SCHROEDER, Elsie A. Schroeder Schneider, Hollis London, Terry Mengers Reel, 

Ted Mengers, Debbie Mengers Quates, August H. Setinmeyer, Carole Schroeder Miller, James 

M. Schroeder, Sally Schroeder Tinanus, James E. Schroeder, Sue Schroeder Stanford, Bill 

Schroeder, Wayne Hennecke, Diane Hennecke Rhodes, Jerri James, W. Tom Hailey, and Peggy 

Hailey,

Appellees

From the 229th Judicial District Court, Jim Hogg County, Texas

Trial Court No. CC-04-143

Honorable Ana Lisa Garza, Judge Presiding

ORDER

The Appellants Motion for Extension of Time to File Reply Brief is GRANTED. The

appellants reply brief is due on April 24, 2015.

_________________________________

Luz Elena D. Chapa, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said 

court on this 6th day of April, 2015.

___________________________________

Keith E. Hottle

Clerk of Court
================================================================================

NUMBER                                                                    SHARES
3843

COMMON SHARES
Par Value $.001


                       P.D.C. Innovative Industries, Inc.
               INCORPORATED UNDER THE LAWS OF THE STATE OF NEVADA

                                                       CUSIP 693275 20 8
THIS CERTIFIES THAT                          SEE REVERSE FOR CERTAIN DEFINITIONS




Is the owner of

         Fully Paid and Non-Assessable Shares of Common Stock, of P.D.C.
Innovative Industries, Inc. transferable only on the books of the Corporation by
the holder hereof in person or by duly authorized attorney upon surrender of
this Certificate properly endorsed.

         This Certificate is not valid unless countersigned and registered by
the Transfer Agent and Registrar. Witness the facsimile seal of the Corporation
and the facsimile signatures of its duly authorized officers.


                                                             Date
/s/ Sandra Sowers                    [SEAL]
-----------------
President



Countersigned:
Florida Atlantic Stock Transfer, Inc.
7130 Nob Hill Road
Tamarac, FL 33321             Transfer agent

================================================================================
Order entered February 17, 2023

In The 

### Court of Appeals Fifth District of Texas at Dallas No. 05 - 23 - 00110 - CV IN THE INTEREST OF N.J., A CHILD On Appeal from the 305th Judicial District Court

Dalla s County, Texas Trial Court Cause No. JC - 21 - 00655 - X

O RDER Before the Court is the February 15, 2023 request of Arturo Neria, Jr., Official Court Reporter for the 305th Judicial District Court, for an extension of time to file the reporter’s record. We G RANT the request and extend the deadline to February 27, 2023 . We caution Mr. Neria that further extension requests in this accelerated appeal involving the termination of appellant’s parental rights will be disfavored.

/s/ ERIN A. NOWELL JUSTICE
```

[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 1089 Introduced in House (IH)]

<DOC>

116th CONGRESS
  1st Session
                                H. R. 1089

To amend the Internal Revenue Code of 1986 to clarify that gain or loss 
  on the sale or exchange of certain coins or bullion is exempt from 
                              recognition.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            February 7, 2019

 Mr. Mooney of West Virginia introduced the following bill; which was 
              referred to the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
To amend the Internal Revenue Code of 1986 to clarify that gain or loss 
  on the sale or exchange of certain coins or bullion is exempt from 
                              recognition.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Monetary Metals Tax Neutrality Act 
of 2019''.

SEC. 2. EXEMPTION FROM RECOGNITION OF GAIN OR LOSS FROM SALE OF CERTAIN 
              COINS OR BULLION.

    (a) In General.--Subchapter O of chapter 1 of the Internal Revenue 
Code of 1986 is amended by inserting after part IV the following new 
part:

               ``PART V--SALE OF CERTAIN COINS OR BULLION

``Sec. 1071. Sale of certain coins or bullion.

``SEC. 1071. SALE OF CERTAIN COINS OR BULLION.

    ``No gain or loss shall be recognized on the sale or exchange of--
            ``(1) gold, silver, platinum, or palladium coins minted and 
        issued by the Secretary at any time, or
            ``(2) refined gold or silver bullion, coins, bars, rounds, 
        or ingots which are valued primarily based on their metal 
        content and not their form.''.
    (b) Clerical Amendment.--The table of parts for subchapter O of 
chapter 1 of such Code is amended by inserting after the item relating 
to part IV the following new item:

             ``Part V. Sale of Certain Coins or Bullion''.

    (c) Effective Date.--The amendments made by this section shall 
apply to sales or exchanges after December 31, 2019.
                                 <all>
```
**Exhibit 32.1**

 

**Certificationof CEO and CFO Pursuant to**

**18 U.S.C. Section 1350,**

**as Adopted Pursuant to**

**Section 906 of the Sarbanes-Oxley Act of 2002**

 

Theundersigned, the Chief Executive Officer and the Chief Financial Officer ofSunstone Hotel Investors, Inc. (the “Company”), pursuant to 18 U.S.C. Section 1350,as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, eachhereby certifies that to his knowledge on the date hereof:

 

(a) TheQuarterly Report on Form 10-Q of the Company for the quarter ended September 30,2010, filed on the date hereof with the Securities and Exchange Commission (the“Report”) fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

 

(b) Informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 
| Date: November 4, 2010 | /s/    Arthur  L. Buser         |
|-----------------------------|-----------------------------------------------------|
|                        | **Arthur L. Buser********Chief Executive Officer**  |
|                        | ** **                                          |
| Date: November 4, 2010 | /s/    Kenneth  E. Cruse        |
|                        | **Kenneth E. Cruse********Chief Financial Officer** |

 

----
Exhibit 4.4


 


June 1, 2022


 


Holder of Warrants to Purchase Common Shares issued on November 16,
2020 and July 2, 2021


 


		Re:	Amendment to Existing Warrants



 


Dear Holder:


 


Reference is hereby made to the offering on or
about the date hereof (the “Offering”) by InMed Pharmaceuticals Inc. (the “Company”) of its common
shares, without par value (“Common Shares”) (collectively, the “Shares”).


 


This letter confirms that, in consideration for
the Holder’s participation in the Offering and purchase of Shares in the Offering (the “Purchase Commitment”),
the Company hereby amends, effective as of the closing of the Offering, the Holder’s existing warrants to purchase up to 444,444
Common Shares at an exercise price of $5.11 per share issued on November 16, 2020 and the Holder’s existing warrants to purchase
up to 4,036,327 Common Shares at an exercise price of $2.848 issued on July 2, 2021 (collectively, the “Existing Warrants”),
by (i) reducing the Exercise Price (as defined therein) of the Existing Warrants to $0.74 per share, (ii) amending the Existing Warrants
so that they will not be exercisable commencing on the date hereof and until six (6) months following the closing of the Offering, and
(iii) amending the expiration date of the Existing Warrants to seven (7) years following the closing of the Offering (the “Warrant
Amendment”). The Warrant Amendment shall be effective upon the closing the Offering and the satisfaction of the other terms
and conditions referenced below.


 


The Warrant Amendment is subject to the consummation
of the Offering and the Holder’s satisfaction of the Purchase Commitment. In the event that either (i) the Offering is not consummated,
or (ii) the Holder does not satisfy the Purchase Commitment, the Warrant Amendment shall be null and void and the provisions of the Existing
Warrants in effect prior to the date hereof shall remain in effect.


 


Except as expressly set forth
herein, the terms and provisions of the Existing Warrants shall remain in full force and effect after the execution of this letter and
shall not be in any way changed, modified or superseded except by the terms set forth herein.


 


From and after the effectiveness of the Warrant
Amendment, the Company agrees to promptly deliver to the Holder, upon request, amended Existing Warrants that reflect the Warrant Amendments
in exchange for the surrender for cancellation of the Holder’s Existing Warrants to be amended as provided herein.


 


[Signature Page Follows]


 



     


     


    

 


IN WITNESS WHEREOF, the parties hereto have caused
this agreement to be duly executed by their respective authorized signatories as of the date first indicated above.


 


InMed Pharmaceuticals Inc.


 


By: _____________________


Name:


Title:


 


Name of Holder: ________________________________________________________


 


Signature of Authorized Signatory of Holder: __________________________________


 


Name of Authorized Signatory: ____________________________________________________


 


[Signature
Page to Warrant Amendment Agreement]
### SERVE D MARC H 16 , 201 0 in ] r ^ ; -nQMlnllO

H U.S . DEPARTMEN T O FTRANSPORTATIO N

OFFIC EO FHEARING S WASHINGTON , D C INTH EMATTE RO F INTERTEC H OVERLOAD , INC . FA A DOCKE T NO . CP10WP000 3 (Civi l Penalty Action ) DM S NO . FAA-2010-019 4
NOTIC EO FASSIGNMEN T O FPROCEEDIN G Thi s proceedin g (heretofore designateda s Cas e No . 2008WP010016 ) ha s bee nassigne dt o Administrativ e La w Judg e Richar dC . Goodwin . Al l future pleading s an dothe r communication s regardin g thi s proceedin g shal l b e serve do nth e Judge , th e FA A Hearin g Docket , an dth e othe r person s o n th e attache dServic e List .

Attachmen t

- Servic e Lis t Rondi e A . Yode r /" ^ J Chie f Administrativ e La w Judg e y /FA A Docke t No . CP10WP000 3 (Civi l Penalty Action ) SERVIC ELIS T ORIGINA L& ON ECOP Y Federal Aviatio n Administratio n 80 0 Independenc e Avenue , S.W . Washington , D C 2059 1 Attention : Hearin g Docke t Clerk , AGC-43 0 Wilbu r Wrigh t Buildin g - Suit e 2W1000 '

ON ECOP Y WilliamH . Schultz , Respondent' s Counse l Schult z Law Firm 3212 3 Linder o Canyo n Road , Suit e 20 3 Westlake Village , C A 91361-541 2 TEL : 818-901-191 9 FAX : 818-901-199 6 Dean Cambe , Sr. , Presiden t Intertec hOverload , Inc. , Responden t 770 1 Woodle y Avenu e VanNuys,C A 9140 6 Courtne y Adolph , Complainant' s Counse l Offic e o f th e Regiona l Coxmse

l Western-Pacifi c Region , AWP- 7 Federa l Aviatio n Administratio n P.O . Bo x 9200 7 Lo s Angeles, C A 90009-200 7 TEL : 310-725-712 8 FAX : 310-725-681 6 Th e Honorabl e Richar dC . Goodwin , Administrativ e Law Judg e Offic e o f Hearings , M-2 0 U.S . Departmen t

o f Transportatio n 120 0 New Jerse y Avenue , S.E . Eas t Buildin g Groun dFloor , Roo mEl2-32 0 Washington , D C 2059 0 TEL : Attorney-Adviso r

202-366-213 9 Legal Assistan t

202-366-512 1

' Servic e wa s b y U.S . Mail . Fo

r servic e i n perso no r b y expedite dcourier , us e th e followin g address : Hearin g Docket , Federa l Aviatio n Administration, 60

0 Independenc

e Avenue, S . W. , Wilbu

r Wrigh t Buildin g - Roo m 2014 , Washington

, D C 20591 , Attention : Hearin

g Docke t Clerk , AGC-430 .

!•« >
[DESCRIPTION] CONSENT OF INDEPENDENT AUDITORS



                                 EXHIBIT 23

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS
                                        

     We consent to the incorporation by reference in this Annual Report 
(Form 10-K) of Betz Laboratories, Inc. of our report dated January 30, 
1996, included in the 1995 Annual Report to Shareholders of Betz 
Laboratories, Inc.

     Our audits also included the financial statement schedule of Betz
Laboratories, Inc. listed in Item 14(a).  This schedule is the responsibility 
of the Company's management.  Our responsibility is to express an opinion on 
this schedule based on our audits.  In our opinion, the financial statement 
schedule referred to above, when considered in relation to the basic financial 
statements taken as a whole, presents fairly in all material respects the 
information set forth therein.

     We consent to the incorporation by reference in the Registration Statement
(Form S-8 No. 33-60557) pertaining to the Betz Laboratories, Inc. Stock Option 
Plan of 1987 of our report dated January 30, 1996, with respect to the financial
statements incorporated herein by reference and our report included in the 
preceding paragraph withrespect to the financial statement schedule included in
the 1995 Annual Report (Form 10-K) of Betz Laboratories, Inc.


ERNST & YOUNG LLP

Philadelphia, Pennsylvania
March 25, 1996



BETZ LABORATORIES INC.
Exhibit 27: Financial Data Schedule
Article 5 of Regulation S-X
(In thousands, except per share amounts)
116TH CONGRESS 

1ST SESSION H. CON. RES. 82 

CONCURRENT RESOLUTION 

1 Resolved by the House of Representatives (the Senate 

2 concurring), That, in the enrollment of the bill H.R. 1865, 

3 the Clerk of the House of Representatives shall make the 

4 following corrections: 

5 (1) Amend the long title so as to read: ‘‘Making 

6 further consolidated appropriations for the fiscal 

7 year ending September 30, 2020, and for other pur8 poses.’’. 
2 

•HCON 82 EH 

1 (2) Strike the first section 1 immediately fol2 lowing the enacting clause and all that follows 

3 through section 9. 

4 (3) In section 101 of title I of division P, strike 

5 the matter in quotes and insert ‘‘Platte River Recov6 ery Implementation Program Extension Act’’. 

7 (4) In the table of contents for subtitle F of 

8 title I of division N, strike the item relating to sec9 tion 601. 

10 (5) Strike section 601 of subtitle F of title I of 

11 division N. 

Passed the House of Representatives December 17, 

2019. 

Attest: 

Clerk. 

116TH CONGRESS 

1ST SESSION H. CON. RES. 82 

CONCURRENT RESOLUTION 

Directing the Clerk of the House of Representatives 

1865. to make a correction in the enrollment of H.R.
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 14-7632

UNITED STATES OF AMERICA,

Plaintiff – Appellee,

v.

JESSYE WAYNE POWELL,

Defendant - Appellant.

Appeal from the United States District Court for the Western 

District of North Carolina, at Charlotte. Robert J. Conrad, 

Jr., District Judge. (3:06-cr-00189-RJC-1; 3:11-cv-00377-RJC)

Submitted: March 13, 2015 Decided: April 7, 2015

Before SHEDD, Circuit Judge, and HAMILTON and DAVIS, Senior 

Circuit Judges.

Dismissed by unpublished per curiam opinion.

Jessye Wayne Powell, Appellant Pro Se. Thomas Richard Ascik, 

Assistant United States Attorney, Asheville, North Carolina; 

Kevin Zolot, OFFICE OF THE UNITED STATES ATTORNEY, Charlotte, 

North Carolina, for Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Jessye Wayne Powell seeks to appeal the district court’s 

order denying relief on his 28 U.S.C. § 2255 (2012) motion. The 

order is not appealable unless a circuit justice or judge issues 

a certificate of appealability. 28 U.S.C. § 2253(c)(1)(B)

(2012). A certificate of appealability will not issue absent “a 

substantial showing of the denial of a constitutional right.” 

28 U.S.C. § 2253(c)(2) (2012). When the district court denies 

relief on the merits, a prisoner satisfies this standard by 

demonstrating that reasonable jurists would find that the 

district court’s assessment of the constitutional claims is 

debatable or wrong. Slack v. McDaniel, 529 U.S. 473, 484 

(2000); see Miller-El v. Cockrell, 537 U.S. 322, 336-38 (2003). 

When the district court denies relief on procedural grounds, the 

prisoner must demonstrate both that the dispositive procedural 

ruling is debatable, and that the motion states a debatable 

claim of the denial of a constitutional right. Slack, 529 U.S. 

at 484-85. 

We have independently reviewed the record and conclude that 

Powell has not made the requisite showing. Accordingly, we deny 

a certificate of appealability and dismiss the appeal. We 

dispense with oral argument because the facts and legal 
3

contentions are adequately presented in the materials before 

this court and argument would not aid the decisional process.

DISMISSED